2 insiders reported 7 Form 4 transactions for Armata Pharmaceuticals, Inc. (ARMP) over the past 18 months (most recent 2026-07-14). Recent activity: Birx Deborah (Chief Executive Officer) Sell 14,041 shares, Kyme Pierre (Chief Business Officer) Sell 1,030 shares, Birx Deborah (Chief Executive Officer) Sell 4,919 shares, Birx Deborah (Chief Executive Officer) Sell 13,637 shares, Kyme Pierre (Chief Business Officer) Sell 1,027 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-14 | Birx Deborah | Chief Executive Officer | Sell | 14,041 | $59,815 |
| 2026-03-17 | Kyme Pierre | Chief Business Officer | Sell | 1,030 | $10,856 |
| 2026-03-17 | Birx Deborah | Chief Executive Officer | Sell | 4,919 | $51,846 |
| 2025-07-14 | Birx Deborah | Chief Executive Officer | Sell | 13,637 | $30,956 |
| 2025-04-25 | Kyme Pierre | Chief Business Officer | Sell | 1,027 | $2,003 |
| 2025-04-25 | Birx Deborah | Chief Executive Officer | Sell | 22,925 | $61,439 |
| 2025-04-25 | Birx Deborah | Chief Executive Officer | Sell | 6,061 | $11,819 |
Source: SEC Form 4 filings · as of 2026-07-14